- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT07337408
Caractérisation des pratiques de sevrage dans les unités de soins intensifs des pays du Sud
Caractérisation des pratiques de sevrage dans les unités de soins intensifs des pays du Sud : une étude observationnelle prospective
This is a prospective observational study to be conducted in intensive care units of Global South countries. Patients on mechanical ventilation for more than 12 hours who have initiated the weaning process and for whom the attending team plans extubation within the next 6 hours will be included. Data will be collected for each patient during the first 7 days after extubation, with follow-up until hospital discharge or death. We plan to conduct the study in intensive care units from Global South countries (low- and middle-income countries predominantly located in the Southern Hemisphere, though some in the Northern Hemisphere are also considered).
Aperçu de l'étude
Statut
Type d'étude
Inscription (Estimé)
Contacts et emplacements
Coordonnées de l'étude
- Nom: Aline B Pereira
- Numéro de téléphone: +55 (47) 99181-8400
- E-mail: linibp@hotmail.com
Lieux d'étude
-
-
Santa Catarina
-
Joinville, Santa Catarina, Brésil
- Recrutement
- Centro Hospitalar Unimed Joinville
-
Contact:
- Braz Pereira
- Numéro de téléphone: 55 47 99181-8400
- E-mail: linibp@hotmail.com
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
Méthode d'échantillonnage
Population étudiée
Patients receiving mechanical ventilation for more than 12 hours who are planning to undergo the first separation attempt from the invasive mechanical ventilation (as defined in the WIND Classification) in the next 6 hours or that has undergone a separation attempt less than 2 hours ago will be included.
La description
Inclusion Criteria:
- Age > 18 years.
- Receiving care at an intensive care unit.
- Endotracheal intubation.
- Mechanical ventilation for 12 hours or more.
- First separation attempt, as defined in the WIND Classification - "Separation attempt from mechanical ventilation: an spontaneous breathing trial with or without extubation, or an extubation directly performed without identified spontaneous breathing trial (whatever the type: planned or unplanned extubation)" - planned to occur in the next 6 hours or that occurred less than 2 hours ago.
Exclusion Criteria:
- Patients with prior extubation failure.
- Patients with prior spontaneous breathing trial failure.
- Patients unable to obey commands.
- Neuromuscular disease or cervical spinal cord injury.
- Tracheostomy.
- Do-not-resuscitate order or contraindication for reintubation.
- Lack of informed consent.
- Terminal extubation.
- Previously included in the study.
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Modèles d'observation: COHORT
- Perspectives temporelles: PROSPECTIVE
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Extubation failure within 7 days.
Délai: 7 days.
|
Defined as reintubation or death within 7 days after extubation. |
7 days.
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Extubation within 28 days.
Délai: 28 days.
|
Defined as extubation within 28 days after first separation attempt. |
28 days.
|
|
Intensive care unit length of stay.
Délai: At intensive care unit discharge, up to 28 days.
|
Defined as the number of days from the time of first separation attempt until discharge from the intensive care unit. |
At intensive care unit discharge, up to 28 days.
|
|
Hospital length of stay.
Délai: At hospital discharge, up to 28 days.
|
Defined as the number of days from the time of first separation attempt until discharge from the hospital. |
At hospital discharge, up to 28 days.
|
|
Reintubation or death within 28 days.
Délai: 28 days.
|
Defined as composite criterion of reintubation or death within 28 days after first separation attempt. |
28 days.
|
|
Intensive care unit mortality.
Délai: At intensive care unit discharge, up to 28 days.
|
Defined as mortality from the time of first separation attempt until discharge from the intensive care unit. |
At intensive care unit discharge, up to 28 days.
|
|
Hospital mortality.
Délai: At hospital discharge, up to 28 days.
|
Defined as mortality from the time of first separation attempt until discharge from the hospital. |
At hospital discharge, up to 28 days.
|
|
Number of spontaneous breathing trials.
Délai: 28 days.
|
Defined as the number of spontaneous breathing trials performed after first separation attempt. |
28 days.
|
|
WIND classification.
Délai: 28 days.
|
Group 1 (short weaning): the first separation attempt resulted in a termination of the weaning process within 24 hours (successful separation or early death). • Group 2 (difficult weaning): weaning was terminated after more than 1 day but in less than 1 week after the first separation attempt (successful separation or death). • Group 3 (prolonged weaning): weaning was still not terminated 7 days after the first separation attempt (by success or death). |
28 days.
|
Collaborateurs et enquêteurs
Parrainer
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Estimé)
Achèvement de l'étude (Estimé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
Autres numéros d'identification d'étude
- GS Wean - Observational
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .